We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$403M
AUM Growth
+$97.4M
Cap. Flow
+$82.6M
Cap. Flow %
20.49%
Top 10 Hldgs %
53.32%
Holding
44
New
6
Increased
29
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.93M
2
PFE icon
Pfizer
PFE
+$8.2M
3
BMY icon
Bristol-Myers Squibb
BMY
+$8.19M
4
MDT icon
Medtronic
MDT
+$7.3M
5
VTRS icon
Viatris
VTRS
+$6.51M

Top Sells

Rank Stock Value
1
QGEN icon
Qiagen
QGEN
+$5.62M
2
TMO icon
Thermo Fisher Scientific
TMO
+$3.28M
3
TGTX icon
TG Therapeutics
TGTX
+$2.95M
4
ELV icon
Elevance Health
ELV
+$2.85M
5
THC icon
Tenet Healthcare
THC
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$31.9M 7.91%
1,252,086
+332,086
+36% +$8.2M
MDT icon
2
Medtronic
MDT
$106B
$28.9M 7.17%
303,441
+79,441
+35% +$7.3M
MRK icon
3
Merck
MRK
$315B
$27.1M 6.71%
322,500
+120,500
+60% +$9.93M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$26.2M 6.5%
581,267
+175,267
+43% +$8.19M
BDX icon
5
Becton Dickinson
BDX
$43.6B
$20.4M 5.05%
108,829
+10,829
+11% +$2.01M
IONS icon
6
Ionis Pharmaceuticals
IONS
$8.99B
$17.7M 4.4%
270,963
-14,879
-5% -$726K
INCY icon
7
Incyte
INCY
$23.4B
$17.4M 4.31%
205,114
+1,114
+0.5% +$88.1K
AMGN icon
8
Amgen
AMGN
$198B
$17.3M 4.3%
61,456
+17,456
+40% +$5.06M
GILD icon
9
Gilead Sciences
GILD
$167B
$16.3M 4.05%
147,239
+20,239
+16% +$2.3M
CVS icon
10
CVS Health
CVS
$137B
$11.8M 2.92%
156,202
-6,798
-4% -$466K
ZBH icon
11
Zimmer Biomet
ZBH
$17.6B
$11.2M 2.77%
113,478
+24,847
+28% +$2.46M
BIIB icon
12
Biogen
BIIB
$30.4B
$10.6M 2.62%
75,475
+24,836
+49% +$3.36M
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$11.5B
$9.52M 2.36%
175,852
+53,504
+44% +$3.06M
CAH icon
14
Cardinal Health
CAH
$53.5B
$9.34M 2.32%
59,536
-6,464
-10% -$998K
TMO icon
15
Thermo Fisher Scientific
TMO
$198B
$8.95M 2.22%
18,444
-7,056
-28% -$3.28M
BAX icon
16
Baxter International
BAX
$11.7B
$8.69M 2.15%
381,551
+113,544
+42% +$2.88M
GEHC icon
17
GE HealthCare
GEHC
$28.7B
$8.37M 2.07%
111,390
+37,390
+51% +$2.79M
BRKR icon
18
Bruker
BRKR
$8.86B
$8.15M 2.02%
250,909
+54,939
+28% +$1.96M
CNC icon
19
Centene
CNC
$32.8B
$7.61M 1.89%
213,210
+61,210
+40% +$1.85M
LH icon
20
Labcorp
LH
$23.2B
$7.45M 1.85%
25,970
+6,486
+33% +$1.74M
PTCT icon
21
PTC Therapeutics
PTCT
$6.52B
$7.25M 1.8%
118,112
+25,862
+28% +$1.35M
VTRS icon
22
Viatris
VTRS
$20.1B
$6.62M 1.64%
+668,851
New +$6.51M
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.15B
$6.4M 1.59%
22,827
+4,998
+28% +$1.36M
HUM icon
24
Humana
HUM
$48B
$6.23M 1.54%
23,942
+442
+2% +$116K
ELAN icon
25
Elanco Animal Health
ELAN
$12.9B
$6.19M 1.53%
307,271
+15,198
+5% +$255K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2025 Portfolio in Review

As of Q3 2025, Sector Gamma AS held 44 positions worth $403M, up 32% from $306M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sector Gamma AS deployed $82.6M of net new capital in Q3 2025, opening 6 new positions and adding to 29 existing holdings. Its largest new stake was Viatris: 668,851 shares worth $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $3.28M trimmed.

  • Sector Gamma AS's largest Q3 2025 buy was Viatris: 668,851 shares worth $6.62M.
  • Sector Gamma AS added most to Merck in Q3 2025, an estimated $9.93M increase.
  • Sector Gamma AS's biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $3.28M.
  • Sector Gamma AS fully exited Qiagen in Q3 2025, selling an estimated $5.62M.
  • Sector Gamma AS's ten largest holdings make up 53% of its $403M portfolio in Q3 2025.
  • Sector Gamma AS opened 6 new positions and closed 3 in Q3 2025.
  • Sector Gamma AS's portfolio value rose 32% quarter-over-quarter to $403M.

Based on Sector Gamma AS's 13F filing for Q3 2025, filed 31 Oct 2025.